Lixte Biotechnology Holdings Inc (LIXT)
2.87
+0.11
(+3.99%)
USD |
NASDAQ |
May 01, 16:00
2.87
0.00 (0.00%)
After-Hours: 20:00
Lixte Biotechnology Holdings Total Assets (Quarterly): 4.309M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.309M |
| September 30, 2023 | 5.235M |
| June 30, 2023 | 3.095M |
| March 31, 2023 | 4.331M |
| December 31, 2022 | 5.561M |
| September 30, 2022 | 6.820M |
| June 30, 2022 | 8.024M |
| March 31, 2022 | 4.118M |
| December 31, 2021 | 5.093M |
| September 30, 2021 | 6.334M |
| June 30, 2021 | 7.243M |
| March 31, 2021 | 7.890M |
| December 31, 2020 | 5.228M |
| September 30, 2020 | 1.362M |
| June 30, 2020 | 1.892M |
| March 31, 2020 | 2.276M |
| December 31, 2019 | 2.672M |
| September 30, 2019 | 3.066M |
| June 30, 2019 | 3.619M |
| March 31, 2019 | 3.955M |
| December 31, 2018 | 4.337M |
| September 30, 2018 | 0.4449M |
| June 30, 2018 | 0.5828M |
| March 31, 2018 | 0.8546M |
| December 31, 2017 | 1.368M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.651M |
| June 30, 2017 | 2.065M |
| March 31, 2017 | 0.9206M |
| December 31, 2016 | 0.4334M |
| September 30, 2016 | 0.9336M |
| June 30, 2016 | 1.379M |
| March 31, 2016 | 1.225M |
| December 31, 2015 | 0.598M |
| September 30, 2015 | 1.027M |
| June 30, 2015 | 1.525M |
| March 31, 2015 | 1.682M |
| December 31, 2014 | 0.5393M |
| September 30, 2014 | 0.9962M |
| June 30, 2014 | 1.302M |
| March 31, 2014 | 0.1879M |
| December 31, 2013 | 0.558M |
| September 30, 2013 | 0.8738M |
| June 30, 2013 | 1.145M |
| March 31, 2013 | 1.481M |
| December 31, 2012 | 1.753M |
| September 30, 2012 | 1.962M |
| June 30, 2012 | 2.255M |
| March 31, 2012 | 0.2016M |
| December 31, 2011 | 0.4298M |
| September 30, 2011 | 1.000M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.362M
Minimum
Sep 2020
8.024M
Maximum
Jun 2022
4.640M
Average
4.331M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| iBio Inc | 34.02M |
| PAVmed Inc | 33.12M |
| PDS Biotechnology Corp | 59.39M |
| Moleculin Biotech Inc | 38.22M |
| Syros Pharmaceuticals Inc | 168.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.3139M |
| Shareholders Equity (Quarterly) | 3.995M |